EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer
Author:
Funder
National Science Council of Taiwan
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Oncology
Reference149 articles.
1. Cell signaling by receptor tyrosine kinases;Lemmon;Cell,2010
2. Clinical significance of ErbB receptor family in urothelial carcinoma of the bladder: a systematic review and meta-analysis;Tsai;Adv. Urol.,2012
3. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder;Chow;Clin. Cancer Res.,2001
4. Humanization of an anti-p185HER2 antibody for human cancer therapy;Carter;Proc. Natl. Acad. Sci. U. S. A.,1992
5. p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma;Nakazawa;Am. J. Clin. Pathol.,2009
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy;Cancer Biomarkers;2024-08-27
2. Effects of Gene Alternative Splicing Events on Resistance to Cryptocaryonosis of Large Yellow Croaker (Larimichthys crocea);Marine Biotechnology;2024-07-06
3. EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer;Molecular Genetics and Genomics;2024-05-14
4. PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis;Cancer Management and Research;2024-03
5. 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors;Molecular Cancer Therapeutics;2024-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3